Taustin, eye drops 4% 10 ml

Pharmacotherapeutic group: Metabolic agent.

ATX code: S01XA

Pharmacological properties

Taurine is a sulfur-containing amino acid formed in the body during conversion of cysteine.

An anti-catabolic agent, it has a metabolic effect. It stimulates the processes of repair and regeneration in diseases of dystrophic nature and diseases accompanied by acute metabolic disorder of eye tissues.

It normalizes cell membrane functions, activates energy and metabolic processes, conserves electrolyte composition of cytoplasm due to accumulation of K⁺ and Ca²⁺, improves conditions of nerve impulse conducting.

Pharmacokinetics

In topical administration, systemic absorption is low.

Indications

The drug is used as part of complex therapy. Corneal dystrophy; cataract (senile, diabetic, traumatic, radiation); corneal trauma (as a stimulator of reparative processes). Primary open-angle glaucoma (in combination with β-adrenoblockers (to improve outflow of intraocular fluid).

Active ingredient

Taurine

Composition

1 ml of the drug contains:

The active ingredient: taurine – 40 mg.

Excipient: water for injection – up to 1 ml.

How to take, the dosage

Topically. The drug is used in the form of instillation.

In case of cataract – 1-2 drops 2-4 times a day for 3 months. The course is repeated at one-month intervals.

In case of trauma and dystrophic corneal diseases, the same doses are used for 1 month.

In open-angle glaucoma (in combination with butylaminohydroxypropoxyphenoxymethyl methyloxadiazole or timololol maleate) 1 to 2 drops 2 times daily 15-20 minutes before prescribing one of the local hypotensive agents, for 6 weeks followed by withdrawal for 2 weeks.

Interaction

In patients with glaucoma (open-angle) a significant enhancement of the hypotensive effect of β-adrenoblockers (butylaminohydroxypropoxyphenoxymethyl methyloxadiazole or timolol maleate) was noted when used together with taurine.

The effect is enhanced by increasing the ease of outflow coefficient and reducing aqueous moisture production.

Special Instructions

If the simultaneous use of other ophthalmic drugs (eye drops, etc.) is necessary, the interval between the use of taurine and other drugs should be at least 10-15 minutes.

Influence on driving and operating ability

The use of the drug does not affect driving and engaging in potentially hazardous activities requiring increased concentration and rapid psychomotor reactions.

Synopsis

A clear colorless liquid.

Contraindications

Increased individual sensitivity, children (under 18 years).

Side effects

Allergic reactions are possible.

If the side effects listed in the instructions worsen, or if you notice any other side effects not listed in the instructions, tell your doctor.

Pregnancy use

Administration of the drug during pregnancy and breastfeeding is possible only if the expected benefits to the mother exceed the potential risk to the fetus or child.

Similarities

Taufon, Dibicor, Taurine, Taurine Renewal, CardioAktiv